Dr. McArthur is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-4673Fax+1 214-645-2615- Is this information wrong?
Summary
- Dr. Heather McArthur is an oncologist in Dallas, TX and is affiliated with University of Texas Southwestern Medical Center. She received her medical degree from University of Toronto Faculty of Medicine, a fellowship degree from the British Columbia Cancer Agency, a Master of Public Health degree from Harvard University and has been in practice 16 years. She specializes in breast cancer and is experienced in breast cancer, oncology, and internal medicine. She has more than 90 publications and over 500 citings.
Education & Training
Memorial-Sloan Kettering Cancer CenterAdvanced Clinical Research Fellowship, Breast Oncology, 2006 - 2010- Harvard UniversityMPH, Clinical Effectiveness, 2006 - 2008
- British Columbia Cancer Agency/University of British ColumbiaMedical Oncology Fellowship, 2004 - 2006
- University of CalgaryInternal Medicine Residency, 2001 - 2004
University of Toronto Faculty of MedicineClass of 2001
Certifications & Licensure
TX State Medical License 2022 - 2024
CA State Medical License 2016 - 2022
NY State Medical License 2009 - 2019
Clinical Trials
- Pre-Operative, Single-Dose Ipilimumab and/or Cryoablation in Early Stage/Resectable Breast Cancer Start of enrollment: 2011 Dec 01
- Breast Cancer Study of Preoperative Pembrolizumab + Radiation Start of enrollment: 2017 Dec 22
- Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer Start of enrollment: 2019 Nov 12
- Join now to see all
Publications & Presentations
PubMed
- Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancer.Elizabeth Comen, Sadna Budhu, Yuval Elhanati, David Page, Teresa Rasalan-Ho, Erika Ritter, Phillip Wong, George Plitas, Sujata Patil, Edi Brogi, Maxine Jochelson, Yola...> ;Iscience. 2024 Feb 16
- 1 citationsSingle-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer.Shiao, S., Gouin, K., Ing, N., Ho, A., Basho, R., Shah, A., Mebane, R., Zitser, D., Martinez, A., Mevises, N., Ben-Cheikh, B., Henson, R., Mita, M., McAndrew, P., Karl...> ;Cancer Cell. 2024 Jan 8
- 12 citationsBrain radiotherapy, tremelimumab-mediated CTLA-4-directed blockade +/- trastuzumab in patients with breast cancer brain metastases.David B Page, Kathryn Beal, Stefanie N Linch, Kateri J Spinelli, Micaela Rodine, Darragh Halpenny, Shanu Modi, Sujata Patil, Robert J Young, Thomas Kaley, Taha Merghou...> ;NPJ Breast Cancer. 2022 Apr 19
- Join now to see all
Lectures
- ALEXANDRA/IMpassion030: A phase III study of standard adjuvant chemotherapy with or without atezolizumab in early-stage triple-negative breast cancer.2019 ASCO Annual Meeting - 6/1/2019
- A phase II, single arm study assessing the efficacy of pembrolizumab (Pembro) plus radiotherapy (RT) in metastatic triple negative breast cancer (mTNBC).2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Press Mentions
Long-Term Neoadjuvant Study Tests Nivolumab in ER+/HER2- Breast CancerJune 1st, 2021
A Promising New Study Suggests Women with an Aggressive Form of Breast Cancer Could Benefit from ImmunotherapyFebruary 14th, 2020
Freezing Breast Cancer Cells May Help Avoid SurgerySeptember 24th, 2019- Join now to see all
Hospital Affiliations
University of Texas Southwestern Medical CenterDallas, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
